DOCS
Doximity, Inc.
Healthcare · Health Information Services · NYQ
$20.59
Data: 2026-05-15
✓ ETHICAL PASS

STRONG MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$3.5B
Total market value of the company
Trailing P/E
19.23
Reasonably valued
Forward P/E
11.86
Based on estimated future earnings — lower means cheaper
Rev Growth
+5.1%
Year-over-year revenue change
Profit Margin
30.4%
How much profit the company keeps from each dollar of revenue
ROE
19.3%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$27.30
+33% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 20 analysts covering this stock
About Doximity, Inc.

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

https://www.doximity.com

Country: United States Industry: Health Information Services
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.2% PASS
Debt must be below 33% of total assets
Cash Ratio
16.8% PASS
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
Fair Value Est.
$19.07
What our model estimates this business is worth per share
Margin of Safety
-8.0%
Trading above fair value — no margin of safety
Rating
STRONG OPPORTUNITY
Overall assessment combining ethics, valuation, and quality
Percentile
99.3th
Ranks in the top 1% of our 13,571 screened universe
Ethical Score
93.6
Valuation Score
77.5
Quality Score
75.3
Combined
79.5

Trading near fair value at $19 (estimated $19). Strong competitive moat. 30% profit margins. Passes all ethical screens. Ranks better than 99% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime
DISTRIBUTION
Smart money appears to be selling into strength — caution
Sharpe Ratio
0.018
Positive but modest risk-adjusted returns
Kelly Fraction
-0.0044
No positive edge detected — the data suggests staying out
Calmar Ratio
-0.225
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-17.7%
Historical annualised return based on price data
Max Drawdown
-78.3%
Largest peak-to-trough decline — the worst it has been
HMM State
CRISIS
Elevated risk detected — extreme caution warranted
Days in State
9
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

Beta
1.35
Moves slightly more than the broader market
52W High
$76.51
73% below the year high
52W Low
$17.15
20% above the year low
Avg Volume
3,444,925
Average daily shares traded — higher means easier to buy and sell
Short Ratio
5.4
Days it would take all short sellers to cover — higher means more crowded
Short % Float
13.0%
Elevated short interest — bears are positioned against this
Div Yield
0.0%
Annual dividend as a percentage of the share price
EPS (TTM)
$1.19
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity
0.01
Conservative use of debt — low financial risk
Current Ratio
6.09
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
5.77
Like current ratio but excludes inventory — stricter test
Gross Margin
89.1%
Revenue left after cost of goods — higher means pricing power
Operating Margin
17.1%
Profit from core operations before interest and tax
Free Cash Flow
$255M
Positive — the business generates more cash than it spends
Revenue (TTM)
$645M
Total revenue over the last 12 months
Net Income
$196M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
20
Target High
$47.00
Target Median
$27.30
Target Low
$18.00
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date Insider Title Type Shares Value
2026-05-15 TANGNEY JEFFREY A. Chief Executive Officer 322,614 —
2026-05-11 SITARAM SIDDHARTH Chief Financial Officer 2,309 $59,503
2026-05-11 SITARAM SIDDHARTH Chief Financial Officer 5,000 —
2026-05-07 WAMPLER KIRA SCHERER Director 9,000 $234,540
2026-05-07 WAMPLER KIRA SCHERER Director 9,000 —
2026-04-10 SITARAM SIDDHARTH Chief Financial Officer 2,427 $51,185
2026-04-10 SITARAM SIDDHARTH Chief Financial Officer 5,000 —
2026-03-10 SITARAM SIDDHARTH Chief Financial Officer 2,319 $58,833
2026-03-10 SITARAM SIDDHARTH Chief Financial Officer 5,000 —
2026-03-03 WAMPLER KIRA SCHERER Director 2,000 $52,000
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.